Tampere Celiac Disease Symposium 2020 – From Genomics to Personalized Health, September 18-19, 2020, Tampere University, Tampere, Finland

• J. A. Syage, et al.: “Latest Latiglutenase Clinical Trial Updates”
• J. Sealey-Voyksner, et al.: “Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients”

International Symposium – Celiac Disease, Now and the Future, March 6-7, 2020, Columbia University, NY

• Jack A. Syage: “Enzymes are Still in the Picture: the Case for Latiglutenase” (Invited Talk)
• Jennifer A. Sealey-Voyksner: “Gluten Detection in Food” (Invited Talk)

Celiac Disease Foundation Patient Advocacy Summit, February 27, 2020, Washington, CD

• Jack A. Syage: “Today and Tomorrow in Biopharmaceutical Research, Treatment and Cure” (Panel Talk)

Beyond Celiac Research Summit, November 14-15, 2019, Baltimore, MD

• Jennifer Sealey-Voyksner: “Getting Over the Peak: The Final Ascent to Realizing Therapies in Celiac Disease.” (panel member)

18th International Celiac Disease Symposium (ICDS) Sept 5-8, 2019, Paris, France

• J. A. Syage, P. H. R. Green, C. Khosla, D. C. Adelman, J. A. Sealey-Voyksner, J. A. Murray: “Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet”
• J. A. Sealey-Voyksner, J. A. Murray, C. Khosla, J. A. Syage: “Minimally-Invasive Monitoring of Intestinal Villous Health in Recovering Celiac Disease Patients”

IV International Conference on Urinomics and Translational Nephrology Sept 2-4, 2019, Caparica, Portugal

• J. A. Syage, C. P. Kelly, A. C. Cebolla Ramirez, F. Leon, R. Dominguez, J. A. Sealey-Voyksner: “Determination of Gluten Consumption in Celiac Disease Patients on a Gluten-Free Diet” (invited talk)

Digestive Diseases Week (DDW), May 18-22, San Diego, CA

• J. A. Syage, et al.: “Responder Analysis for Latiglutenase Reduction in Symptoms for Celiac Disease Patients” 
• J. A. Sealey-Voyksner, et al.: “Minimally-Invasive Monitoring of Intestinal Villous Health in Recovering Celiac Disease Patients”
• J.A. Syage, et al.: “Latiglutenase Improves Quality of Life in Seropositive Celiac Disease Patients”
• A. C. Bledsoe, et al.: “Utility of Symptom Severity, Frequency, and Lability in Predicting Serology Status and Villous Injury in Symptomatic Adults with Treated Celiac Disease”

Tampere Celiac Disease Symposium 2018 – Serology and Biomarkers, September 13-15, 2018, University of Tampere, Tampere, Finland

• J. A. Syage, et al.: “Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients” (talk)
• J. A. Sealey-Voyksner, et al.: “Determination of Gluten Consumption by Celiac Disease Patients on a Gluten-Free Diet” (poster)
• J. A. Syage, et al.: “Correlation of Histologic and Symptomatic Response in a Celiac Trial for Latiglutenase” (poster)

Digestive Diseases Week (DDW), June 2-5, Washington, DC

• J. A. Syage, et al.: “Determination of Gluten Consumption by Celiac Disease Patients on a Gluten-Free Diet” 
• J. A. Sealey-Voyksner, et al.: “Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients”
• J.A. Syage, et al.: “Correlation of Histologic, Serologic, and Symptomatic Measures of Celiac Disease Patients Participating in a Latiglutenase Clinical Trial”

Celiac Disease Foundation National Conference – Progress and Promise in the Treatment of Celiac Disease, May 4-5, 2018, Pasadena, CA

• Jennifer A. Sealey-Voyksner: “Living Gluten-Free to Live” (invited talk)
• Jack A. Syage: “Progress and Promise in the Treatment of Celiac Disease” (invited talk)

International Symposium – Celiac Disease, Now and the Future, March 1-3, 2018, Columbia University, NY

• Jack A. Syage: “Latiglutenase Really Works!” (invited talk)
• Jennifer A. Sealey-Voyksner: “Skip the ELISA: Liquid Chromatography-Mass Spectrometry” (invited talk)

Celiac Symposium, Nov 17, 2017, Stanford, CA

• J. Sealey-Voyksner: “Non-Dietary Therapies for Celiac Disease” (invited talk)

American Association of Pharmaceutical Scientists (AAPS) Nov 12-15, 2017, San Diego, CA

• J. Sealey-Voyksner, J. Murray, C. Khosla, J. Syage: “Monitoring Simvastatin Metabolism using LC/MS as a Diagnostic Tool for Celiac Disease Activity”

17th International Celiac Disease Symposium (ICDS) Sept 8-10, 2017, New Delhi, India

• J. A. Syage, J. A. Murray, Peter H. R. Green, J. A. Sealey-Voyksner, C. Khosla: “Latiglutenase Symptom Response for Seropositive vs. Seronegative Celiac Disease Patients” (talk)
• J. A. Sealey-Voyksner, J. A. Murray, M. Dickason, C. Khosla, J. A. Syage: “Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients” (talk)
• J. A. Syage, , P. T. Lavin, J. A. Sealey-Voyksner “Relationship Between Gluten Consumption and Symptom Severity for Celiac Disease Patients on a Gluten-Free Diet” (poster)

American Society of Mass Spectrometry (ASMS) Annual Meeting, June 4-8, 2017, Indianapolis, IN

• J. A. Sealey-Voyksner, J. A. Syage, J. A. Murray, C. Khosla: “Monitoring Simvastatin Metabolism using LC/MS as a Diagnostic Tool for Celiac Disease Activity”

Digestive Diseases Week (DDW), May 6-9, 2017, Chicago, IL

• Jack A. Syage: “Oral Latiglutenase Improves Chronic Symptoms in Seropositive Celiac Disease Patients” (Lecture Presentation)
• J. A. Syage, M. A. Dickason, J. A. Sealey-Voyksner: “Celiac Disease Patients Practicing a Gluten-Free Diet Still Consume Unsafe Levels of Gluten”

Biotech Showcase, Jan 9-11, 2017, San Francisco, CA

• Jack A. Syage: “Advanced Therapy and Diagnostic to Manage Celiac Disease” 

Medical Devices Investment Forum, Oct 28, 2016, Newport Beach, CA

• Jack A. Syage: “Advanced Therapy and Diagnostic to Manage Celiac Disease” (invited talk)

Pharmaceutical Strategy Conference, Sept 28-30, 2016, New York, NY

• Jack A. Syage: “The Novel Use of Proprietary Enzymes for the Treatment of Celiac Disease” (invited talk)

AOAC Annual Meeting, Sept 18-21, 2016, Dallas, TX

• JA Sealey-Voyksner: “Towards a validated multiplexed LC-MS method for the detection of allergens and gluten in processed, fermented, hydrolyzed and distilled foods” (invited talk)

AOAC Annual Meeting, Sept. 27-30, 2015, Los Angeles, CA

• JA Sealey-Voyksner, J. Zeigenbaum, R. D. Voyksner: “Authenticity of Spice: Detection and Quantitation of Allergens”
• JA Sealey-Voyksner, J. Zeigenbaum, R. D. Voyksner: “Discovery of Unique Marker Peptides for Effective Detection of Soy and Wheat in Soy Sauce”

NACRW, July 19-22, 2015, St. Pete Beach, FL

• JA Sealey-Voyksner, J. Zeigenbaum, R. D. Voyksner: “Authenticity of Spice using LC/MS”

DDW 2015, May 16-19, Washington, DC

• S Nazareth, B Lebwohl, JA Sealey Voyksner and PHR Green: “Widespread Contamination of Probiotics with Gluten, Detected with Liquid Chromatography/Mass Spectrometry”

ASMS Annual Meeting, May 31-June 4, 2015, St. Louis, MO

MSACL 2015 Clinical Mass Spectrometry Conference, March 28-April 1, 2015, San Diego, CA

30th Montreux LC/MS Symposium – Food Allergens and Safety, Nov. 5-7, 2014, Charleston, SC, USA

• JA Syage, JA Sealey-Voyksner, C Khosla: “Metabolic Diagnostic for Celiac Disease Dietary Management by LC/MS” (invited talk)
• JA Sealey-Voyksner: “Multiplexed LC-MS assay for green plant-based allergens”
• ImmunogenX – Silver Sponsor

AACC International Annual Meeting, October 5-8, Providence, RI

• JA Sealey-Voyksner: “Gluten Detection and Quantitation in Food and Beverages Using a Multiplexed LC-MS Screening Method Based on Grain Specific Marker Peptides” (invited talk)

Separation Science Webinar – Advances in Food Safety Analysis, Sept 23, 2014

• JA Sealey-Voyksner: “Multiplexed LC-MS Screening Method for the Simultaneous Detection of Various Plant-Based Allergens and Gluten” (invited talk)

AOAC Annual Meeting, Sept. 7-10, 2014, Boca Raton, FL

• JA Sealey-Voyksner: “Qualitative and Quantitative Detection of Wheat, Barley and Rye Gluten in Beer by LC-MS” (invited talk)
• JA Sealey-Voyksner: “Towards the Validation of a new LC-MS Screening Method for the Simultaneous Detection and Quantitation of Multiple Plant-Based Allergens” (invited talk)
• JA Sealey-Voyksner: “The Discovery of Unique Marker Peptides for Detection of Trace Levels of Soy in Food Using LC/MS”

NACRW Annual Meeting, July 21-23, 2014, St. Pete, FL

• JA Sealey-Voyksner: “Moving Food Safety to Peptides- New Approaches using LC-MS for the Detection of Plant Allergens”

ASMS Annual Meeting, June 15-19, 2014, Baltimore, MD

• JA Sealey-Voyksner: “Simultaneous Screening of Multiple Plant-based Allergens and Gluten using Liquid Chromatography-Mass Spectrometry”

AOAC 33rd Annual Midwest Meeting, June 2-5, 2014, Oak Brook, IL

• JA Sealey-Voyksner: “LC-MS Screening Method for Multiple Plant-Based Allergens and Gluten” (invited talk)

8th Workshop on Food Allergens Methodologies, May 7, 2014, Vancouver, BC, Canada

• JA Sealey-Voyksner: “LC-MS Screening Method for Multiple Plant-Based Allergens and Gluten” (invited talk)
• JA Sealey-Voyksner: “Qualitative and Quantitative Detection of Wheat, Barley and Rye Gluten in Beer by LC-MS”

NASSCD: Therapies for Celiac Disease Conference, Mar. 20-21, 2014, Columbia University, NY

• JA Sealey-Voyksner: “Gluten Detection in the Food Chain” (invited talk)

MSACL 2014 Clinical Mass Spectrometry Conference, Mar. 1-5, 2014, San Diego, CA

• JA Syage, J Sealey-Voyksner, C. Khosla: “Non-invasive, in-situ screen for celiac disease management”
• JA Sealey-Voyksner: “Qualitative and Quantitative Detection of Plant-based allergens by LC-MS”